A nonprofit CRO formed by several ex-DuPont scientists will start operating at a new lab on Oct.1.

Parexel says it has delivered revenue “beyond expectation” in one of its last financials before being merged into Pamplona Capital Management.

Nonclinical service CRO Envigo is merging with publicly traded Avista Healthcare Public Acquisition Corporation.

Charles River Laboratories is buying CRO Brains On-Line for €18 million as it further strengthens its offers in CNS early-stage drug research.

Icon strengthens real-world evidence offerings by acquiring health research and commercialization company Mapi.

German CRO Evotec is acquiring U.S. counterpart Aptuit in a $300 million deal.

Science Exchange has raised $28 million in its third funding round.

WuXi Biologics is pricing its shares at HK$20.60, the top end of its marketing range, valuing the IPO at $510 million, Bloomberg reports.

Outcome Health, a healthcare intelligence tech firm, has raised an outsize $500 million first round of funding, valuing it at $5.5 billion.

Financials